AC-429

N/A

Report date: 2025/01/26 18:30:25
NME

Base Information

Drug NameAC-429
Drug Alias NameLIMK/ROCK inhibitors (CNRS)LIMK-1 inhibitors (CNRS)pyridocarbazoles (CNRS)AC-429
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLIM domain kinase 2 inhibitorsRho-associated protein kinase 1 inhibitorsLIM domain kinase 1 inhibitors +[4] 
TargetsLIM domain kinase 1Rho-associated protein kinase 1Rho-associated protein kinase 2 +[4] 
Therapy Area/IndicationsOsteosarcomaNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCentre National De La Recherche Scientifique (Cnrs)
China Registration ClassN/A

Develop Information

Active CompaniesCentre National De La Recherche Scientifique (Cnrs)
Inactive CompaniesCNRS Innovation
Active IndicationsOsteosarcoma
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A